Effect of a marine extract on body composition and strength in healthy middle-aged women using an open-label design

Pharmalink International Pty Ltd0 个研究点目标入组 61 人开始时间: 2022年7月29日最近更新: 2023年10月9日

适应症

试验速览

暂无简介。

•Pre- and post menopausal women
•Not physically or mentally impacted by a severe acute or chronic medical condition
•Persons with Type 2 diabetes, well-controlled with or without medication, for greater than six months, will be eligible
•Persons on stable blood pressure or lipid medication for greater than three months will be eligible as long there is no diagnosis of a major cardiovascular disease.
•BMI greater than 18 and less than 35

•Women with osteoporosis
•Peri-menopausal women
•Having a pacemaker or other metallic implants
•Smokers, including vaping
•Allergy to shellfish, green-lipped mussels or Antarctic krill
•Pregnant or breast-feeding or planning to become pregnant in the next 6 months.
•Alcohol or drug addiction.
•Inability to cease taking current alternative medicines for the duration of the trial.
•Persons with kidney disease or impaired kidney function
•Persons with oedema
•Persons with severe vertigo

发起方

Pharmalink International Pty Ltd